List of Figures |
Figure 1‑1: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (1 of 4) | 5 |
Figure 1‑2: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (2 of 4) | 5 |
Figure 1‑3: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (3 of 4) | 5 |
Figure 1‑4: Peripheral Vascular Device Market Share Ranking by Segment, Europe, 2022 (4 of 4) | 6 |
Figure 1‑5: Companies Researched in This Report | 7 |
Figure 1‑6: Factors Impacting the Peripheral Market by Segment, Europe (1 of 4) | 8 |
Figure 1‑7: Factors Impacting the peripheral Market by Segment, Europe (2 of 4) | 9 |
Figure 1‑8: Factors Impacting the peripheral Market by Segment, Europe (3 of 4) | 10 |
Figure 1‑9: Factors Impacting the peripheral Market by Segment, Europe (4 of 4) | 11 |
Figure 1‑10: Recent Events in the Peripheral Vascular Device Market, Europe, 2019 – 2023 | 12 |
Figure 1‑11: Peripheral Vascular Device Procedures Covered, Europe (1 of 3) | 13 |
Figure 1‑12: Peripheral Vascular Device Procedures Covered, Europe (2 of 3) | 14 |
Figure 1‑13: Peripheral Vascular Device Procedures Covered, Europe (3 of 3) | 15 |
Figure 1‑14: Peripheral Vascular Device Markets Covered, Europe (1 of 3) | 16 |
Figure 1‑15: Peripheral Vascular Device Markets Covered, Europe (2 of 3) | 17 |
Figure 1‑16: Peripheral Vascular Device Markets Covered, Europe (3 of 3) | 18 |
Figure 1‑17: Key Report Updates | 19 |
Figure 1‑18: Version History | 20 |
Figure 2‑1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2) | 38 |
Figure 2‑2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2) | 39 |
Figure 2‑3: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2) | 40 |
Figure 2‑4: Peripheral Vascular Device Market by Segment, Base Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2) | 41 |
Figure 2‑5: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 – 2029 (€M) (1 of 2) | 42 |
Figure 2‑6: Peripheral Vascular Device Market by Segment, Best Case Scenario, Europe, 2019 – 2029 (€M) (2 of 2) | 43 |
Figure 4‑1: Peripheral Vascular Stent by Company (1 of 2) | 58 |
Figure 4‑2: Peripheral Vascular Stent by Company (2 of 2) | 59 |
Figure 4‑3: PTA Balloon Catheter by Company (1 of 3) | 60 |
Figure 4‑4: PTA Balloon Catheter by Company (2 of 3) | 61 |
Figure 4‑5: PTA Balloon Catheter by Company (3 of 3) | 62 |
Figure 4‑6: Drug-Coated Balloon by Company | 64 |
Figure 4‑7: Atherectomy Device by Company (1 of 2) | 65 |
Figure 4‑8: Atherectomy Device by Company (2 of 2) | 66 |
Figure 4‑9: Lithotripsy Device by Company | 67 |
Figure 4‑10: Chronic Total Occlusion Device by Company | 69 |
Figure 4‑11: Surgical Graft by Company (1 of 2) | 70 |
Figure 4‑12: Surgical Graft by Company (2 of 2) | 71 |
Figure 4‑13: Stent Graft by Company | 72 |
Figure 4‑14: Embolic Protection Device by Company | 73 |
Figure 4‑15: Peripheral Thrombus Management by Company | 76 |
Figure 4‑16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2) | 77 |
Figure 4‑17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2) | 78 |
Figure 4‑18: Carotid Shunt by Company | 79 |
Figure 4‑19: Diagnostic and Interventional Catheters by Company (1 of 2) | 81 |
Figure 4‑20: Diagnostic and Interventional Catheters by Company (2 of 2) | 82 |
Figure 4‑21: Diagnostic and Interventional Guidewire by Company (1 of 3) | 83 |
Figure 4‑22: Diagnostic and Interventional Guidewire by Company (2 of 3) | 84 |
Figure 4‑23: Diagnostic and Interventional Guidewire by Company (3 of 3) | 85 |
Figure 4‑24: Introducer Sheath by Company (1 of 2) | 87 |
Figure 4‑25: Introducer Sheath by Company (2 of 2) | 88 |
Figure 4‑26: Vascular Closure Device by Company | 90 |
Figure 4‑27: Transcatheter Embolization Devices by Company (1 of 2) | 92 |
Figure 4‑28: Transcatheter Embolization Devices by Company (2 of 2) | 93 |
Figure 4‑29: Peripheral IVUS Catheter by Company | 94 |
Figure 4‑30: Class 2 Device Recall VENOVO Venous Stent System | 95 |
Figure 4‑31: Class 1 Device Recall VICI VENOUS STENT System | 95 |
Figure 4‑32: Class 2 Device Recall ELUVIA | 95 |
Figure 4‑33: Class 2 Device Recall PALMAZ GENESIS | 96 |
Figure 4‑34: Class 2 Device Recall S.M.A.R.T. Flex | 96 |
Figure 4‑35: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System | 96 |
Figure 4‑36: Class 2 Device Recall Cordis S.M.A.R.T. CONTROL /S.M.A.R.T. Vascular Stent System | 96 |
Figure 4‑37: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System | 97 |
Figure 4‑38: Class 2 Device Recall Cordis Precise Nitinol Stent System | 97 |
Figure 4‑39: Class 2 Device Recall Formula 418 Renal BalloonExpandable Stent | 97 |
Figure 4‑40: Class 2 Device Recall Zilver 635 Biliary Stent | 97 |
Figure 4‑41: Class 2 Device Recall Zilver 518 Biliary Stent | 98 |
Figure 4‑42: Class 1 Device Recall Atrium | 98 |
Figure 4‑43: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent | 98 |
Figure 4‑44: Class 2 Device Recall Medtronic Abre | 98 |
Figure 4‑45: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System | 99 |
Figure 4‑46: Class 2 Device Recall ENROUTE Transcarotid Stent System | 99 |
Figure 4‑47: Class 2 Device Recall GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROSTHESIS | 99 |
Figure 4‑48: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter | 100 |
Figure 4‑49: Class 2 Device Recall Conquest 40 PTA Dilatation Catheter | 100 |
Figure 4‑50: Class 2 Device Recall Cordis SABER PTA Balloon Dilation Catheter | 100 |
Figure 4‑51: Class 2 Device Recall Cordis POWERFLEX P3, PTA Dilation Catheter | 101 |
Figure 4‑52: Class 2 Device Recall Cordis MAXI LD PTA Dilatation Catheter | 101 |
Figure 4‑53: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter | 101 |
Figure 4‑54: Class 1 Device Recall ADVANCE ENFORCER 35 FOCAL FORCE PTA BALLOON CATHETER | 101 |
Figure 4‑55: Class 2 Device Recall Medtronic IN.PACT Admiral, Paclitaxelcoated PTA Balloon Catheter | 102 |
Figure 4‑56: Class 2 Device Recall Chameleon PTA Balloon Dilation Catheter | 102 |
Figure 4‑57: Class 2 Device Recall Boston Scientific ROTAPRO | 103 |
Figure 4‑58: Class 2 Device Recall STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM | 103 |
Figure 4‑59: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM | 103 |
Figure 4‑60: Class 1 Device Recall TurboHawk Plus | 103 |
Figure 4‑61: Class 1 Device Recall HawkOne | 104 |
Figure 4‑62: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System | 105 |
Figure 4‑63: Class 1 Device Recall IntraClude IntraAortic Occlusion Device | 106 |
Figure 4‑64: Class 2 Device Recall Intergard Woven Vascular Graft | 107 |
Figure 4‑65: Class 2 Device Recall Interavascular SAS/Getinge | 107 |
Figure 4‑66: Class 2 Device Recall Hemashield Gold Knitted Bifurcated | 107 |
Figure 4‑67: Class 2 Device Recall Atrium ADVANTA VXT Vascular Graft | 107 |
Figure 4‑68: Class 2 Device Recall HEMASHIELD MICROVEL Double Velour Knitted Vascular Grafts | 108 |
Figure 4‑69: Class 2 Device Recall HEMASHIELD PLATINUM WOVEN/MICROVEL DOUBLE VELOUR VASCULAR GRAFTS | 108 |
Figure 4‑70: Class 2 Device Recall HEMASHIELD PLATINUM Woven Double Velour Vascular Graft | 108 |
Figure 4‑71: Class 2 Device Recall VASCUTEK/TERUMO | 109 |
Figure 4‑72: Class 2 Device Recall Gore Propaten Vascular Graft | 109 |
Figure 4‑73: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System | 110 |
Figure 4‑74: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft | 110 |
Figure 4‑75: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System | 110 |
Figure 4‑76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft | 110 |
Figure 4‑77: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft | 111 |
Figure 4‑78: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft | 111 |
Figure 4‑79: Class 2 Device Recall Zenith Alpha SpiralZ Endovascular Leg | 111 |
Figure 4‑80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft | 111 |
Figure 4‑81: Class 2 Device Recall Endurant, Endurant II and Endurant IIs Stent Graft Systems | 112 |
Figure 4‑82: Class 2 Device Recall Endurant Stent Graft System | 112 |
Figure 4‑83: Class 2 Device Recall Endurant II Stent Graft System | 112 |
Figure 4‑84: Class 2 Device Recall Endurant II/IIs Stent Graft System | 112 |
Figure 4‑85: Class 2 Device Recall Endurant II/IIs Stent Graft System | 113 |
Figure 4‑86: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System | 113 |
Figure 4‑87: Class 2 Device Recall EKOS | 114 |
Figure 4‑88: Class 2 Device Recall EkoSonic Endovascular Device | 114 |
Figure 4‑89: Class 2 Device Recall EKOS Control System | 114 |
Figure 4‑90: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System | 114 |
Figure 4‑91: Class 1 Device Recall ArrowTrerotola PTD | 115 |
Figure 4‑92: Class 1 Device Recall ArrowTrerotola Percutaneous Thrombolytic Device | 115 |
Figure 4‑93: Class 1 Device Recall ArrowTrerotola OverTheWire PTD Kit Percutaneous Thrombolytic Device: 7FR | 115 |
Figure 4‑94: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific | 116 |
Figure 4‑95: Class 3 Device Recall Cook | 117 |
Figure 4‑96: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set | 117 |
Figure 4‑97: Class 2 Device Recall SoftVu Omni Flush Angiographic Catheter | 118 |
Figure 4‑98: Class 2 Device Recall SEEKER(R) Crossing Support Catheter | 118 |
Figure 4‑99: Class 1 Device Recall Imager II 5F Angiographic Catheter | 118 |
Figure 4‑100: Class 1 Device Recall SUPER TORQUE MB 5F PIG | 118 |
Figure 4‑101: Class 1 Device Recall CrossCath Support Catheter | 119 |
Figure 4‑102: Class 2 Device Recall Torcon NB Advantage | 119 |
Figure 4‑103: Class 2 Device Recall Amplatz extra Stiff Wire Guide | 120 |
Figure 4‑104: Class 2 Device Recall Bentson Wire Guide | 120 |
Figure 4‑105: Class 2 Device Recall Cope Mandril Wire Guide | 120 |
Figure 4‑106: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol) | 120 |
Figure 4‑107: Class 2 Device Recall Coons Interventional Wire Guide | 121 |
Figure 4‑108: Class 2 Device Recall Lunderquist Ring Torque Wire Guide | 121 |
Figure 4‑109: Class 2 Device Recall Newton Wire Guide | 121 |
Figure 4‑110: Class 2 Device Recall Roadrunner PC Hydrophilic Wire Guide | 121 |
Figure 4‑111: Class 2 Device Recall Roadrunner PC Wire Guide (Nimble Floppy) | 122 |
Figure 4‑112: Class 2 Device Recall Roadrunner PC Wire Guide (The Firm) | 122 |
Figure 4‑113: Class 2 Device Recall Cook Roadrunner UniGlide Hydrophilic Wire Guide | 122 |
Figure 4‑114: Class 2 Device Recall Cook Roadrunner PC Wire Guide | 123 |
Figure 4‑115: Class 2 Device Recall Roadrunner Hydrophilic PC Wire Guide | 123 |
Figure 4‑116: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath | 124 |
Figure 4‑117: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER | 124 |
Figure 4‑118: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER | 124 |
Figure 4‑119: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS INTRODUCER | 124 |
Figure 4‑120: Class 2 Device Recall Avanti Catheter Sheath Introducer | 125 |
Figure 4‑121: Class 2 Device Recall | 125 |
Figure 4‑122: Class 2 Device Recall Flexor CheckFlo Introducer | 125 |
Figure 4‑123: Class 1 Device Recall Flexor CheckFlo Introducer | 126 |
Figure 4‑124: Class 2 Device Recall Hilal Embolization Microcoil | 127 |
Figure 4‑125: Class 2 Device Recall Nester Embolization Microcoil | 127 |
Figure 4‑126: Class 2 Device Recall Tornado Embolization Microcoil | 127 |
Figure 4‑127: Class 2 Device Recall Terumo AZUR Peripheral Coil System, Detachable 18 | 127 |
Figure 4‑128: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil | 128 |
Figure 4‑129: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 18, CX Coil | 128 |
Figure 4‑130: Class 2 Device Recall OptiCross 35 15 MHz Peripheral Imaging Catheter | 129 |
Figure 4‑131: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion | 131 |
Figure 4‑132: Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM) | 131 |
Figure 4‑133: Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE) | 132 |
Figure 4‑134: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects With Peripheral Arterial Disease (HEAL) | 132 |
Figure 4‑135: SOLARIS Peripheral PMCF Trial | 132 |
Figure 4‑136: A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femoro-popliteal Artery Disease | 133 |
Figure 4‑137: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY) | 133 |
Figure 4‑138: Stella Supera Siberia | 134 |
Figure 4‑139: A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries (REGAL) | 134 |
Figure 4‑140: Zilver® PTX® V Clinical Study | 135 |
Figure 4‑141: In-Stent Restenosis Post-Approval Study | 135 |
Figure 4‑142: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR) | 136 |
Figure 4‑143: VIVO Clinical Study | 137 |
Figure 4‑144: ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients With Below the Knee Vessel Disease | 138 |
Figure 4‑145: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon | 138 |
Figure 4‑146: Ranger™ and Ranger™ SL (OTW) DCB in China | 139 |
Figure 4‑147: The VaSecure BTK Study | 139 |
Figure 4‑148: Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA) | 140 |
Figure 4‑149: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT) | 141 |
Figure 4‑150: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND) | 141 |
Figure 4‑151: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA) | 142 |
Figure 4‑152: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA | 142 |
Figure 4‑153: Compare I Pilot Study for the Treatment of Subjects With Symptomatic Femoropopliteal Artery Disease | 143 |
Figure 4‑154: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS) | 143 |
Figure 4‑155: IN.PACT Global Clinical Study | 144 |
Figure 4‑156: ILLUMENATE Pivotal Post-Approval Study (PAS) | 144 |
Figure 4‑157: BIOLUX P-III BENELUX All-Comers Registry | 144 |
Figure 4‑158: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB) | 145 |
Figure 4‑159: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN) | 146 |
Figure 4‑160: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA | 146 |
Figure 4‑161: Revascularization of Total or Sub-total Occluded Peripheral Arteries With ByCross® Device. Post Market Clinical Follow-up | 147 |
Figure 4‑162: Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease (PATHFINDER-I) | 147 |
Figure 4‑163: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon | 148 |
Figure 4‑164: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (INSIGHT) | 148 |
Figure 4‑165: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment | 149 |
Figure 4‑166: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II) | 149 |
Figure 4‑167: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY) | 150 |
Figure 4‑168: Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System | 151 |
Figure 4‑169: SOLUTION Trial in China | 151 |
Figure 4‑170: Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+) | 152 |
Figure 4‑171: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) | 152 |
Figure 4‑172: A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER) | 153 |
Figure 4‑173: Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access | 153 |
Figure 4‑174: Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study | 154 |
Figure 4‑175: Post-Approval Study of the TREO Abdominal Stent-Graft System (TREO PAS) | 154 |
Figure 4‑176: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease | 155 |
Figure 4‑177: Zenith Alpha™ Abdominal Endovascular Graft | 155 |
Figure 4‑178: Fenestrated AAA Endovascular Graft Post-Approval Study | 156 |
Figure 4‑179: transShield Embolic Protection System Feasibility Study | 157 |
Figure 4‑180: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System | 158 |
Figure 4‑181: Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER) | 158 |
Figure 4‑182: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System (STRIDE) | 159 |
Figure 4‑183: FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) | 159 |
Figure 4‑184: JETi Peripheral Thrombectomy Registry (JETi) | 160 |
Figure 4‑185: Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever | 160 |
Figure 4‑186: Forceps vs. Snare IVC Filter Removal | 161 |
Figure 4‑187: Predictors of Attempted Inferior Vena Cava Filters Retrieval | 161 |
Figure 4‑188: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter | 162 |
Figure 4‑189: Cook IVC Filter Study (CIVC) | 162 |
Figure 4‑190: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) | 163 |
Figure 4‑191: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal) | 164 |
Figure 4‑192: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial | 164 |
Figure 4‑193: Vascular Closure Device in Transcatheter Aortic Valve Replacement | 165 |
Figure 4‑195: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) | 166 |
Figure 4‑196: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds | 167 |
Figure 4‑197: Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs) | 167 |
Figure 4‑198: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization | 168 |
Figure 4‑199: CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS) | 168 |
Figure 4‑200: LC Bead LUMI for Prostatic Artery Embolization | 169 |
Figure 5‑1: Currency Exchange Rate, 2022 | 172 |
Figure 5‑2: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (€M) (1 of 3) | 175 |
Figure 5‑3: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (€M) (2 of 3) | 176 |
Figure 5‑4: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (€M) (3 of 3) | 177 |
Figure 5‑5: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (US$M) (1 of 3) | 178 |
Figure 5‑6: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (US$M) (2 of 3) | 179 |
Figure 5‑7: Peripheral Vascular Device Market by Segment, Europe, 2019 – 2029 (US$M) (3 of 3) | 180 |
Figure 5‑8: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (1 of 4) | 191 |
Figure 5‑9: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (2 of 4) | 192 |
Figure 5‑10: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (3 of 4) | 193 |
Figure 5‑11: Leading Competitors, Peripheral Vascular Device Market, Europe, 2022 (4 of 4) | 194 |
Figure 5‑12: SWOT Analysis, Abbott (1 of 2) | 213 |
Figure 5‑13: SWOT Analysis, Abbott (2 of 2) | 214 |
Figure 5‑14: SWOT Analysis, Becton Dickinson (1 of 2) | 215 |
Figure 5‑15: SWOT Analysis, Becton Dickinson (2 of 2) | 216 |
Figure 5‑16: SWOT Analysis, Boston Scientific | 217 |
Figure 5‑17: SWOT Analysis, Cardinal Health | 218 |
Figure 5‑18: SWOT Analysis, Cardiovascular Systems, Inc. | 219 |
Figure 5‑19: SWOT Analysis, Cook Medical | 220 |
Figure 5‑20: SWOT Analysis, Medtronic | 221 |
Figure 5‑21: SWOT Analysis, Penumbra | 222 |
Figure 5‑22: SWOT Analysis, Philips | 223 |
Figure 5‑23: SWOT Analysis, Shockwave Medical | 224 |
Figure 5‑24: SWOT Analysis, Silk Road Medical | 225 |
Figure 5‑25: SWOT Analysis, Terumo (1 of 2) | 226 |
Figure 5‑26: SWOT Analysis, Terumo (2 of 2) | 227 |
Figure 5‑27: SWOT Analysis, W.L. Gore | 228 |
Figure 7‑1: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029 (1 of 3) | 242 |
Figure 7‑2: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029 (2 of 3) | 243 |
Figure 7‑3: Peripheral Vascular Device Procedures by Segment, Europe, 2019 – 2029 (3 of 3) | 244 |
Figure 7‑4: Peripheral Vascular Stent Procedures by Country, Europe, 2019 – 2029 | 247 |
Figure 7‑5: Arterial Stent Procedures by Device Type, Europe, 2019 – 2029 | 248 |
Figure 7‑6: Arterial Stent Procedures by Country, Europe, 2019 – 2029 | 249 |
Figure 7‑7: Bare-Metal Stent Procedures by Indication, Europe, 2019 – 2029 | 250 |
Figure 7‑8: Bare-Metal Stent Procedures by Country, Europe, 2019 – 2029 | 251 |
Figure 7‑9: Bare-Metal Carotid Stent Procedures by Country, Europe, 2019 – 2029 | 252 |
Figure 7‑10: Bare-Metal Iliac Stent Procedures by Country, Europe, 2019 – 2029 | 253 |
Figure 7‑11: Bare-Metal Renal Stent Procedures by Country, Europe, 2019 – 2029 | 254 |
Figure 7‑12: Bare-Metal Fem-Pop Stent Procedures by Country, Europe, 2019 – 2029 | 255 |
Figure 7‑13: Bare-Metal Infra-Pop Stent Procedures by Country, Europe, 2019 – 2029 | 256 |
Figure 7‑14: Covered Stent Procedures by Indication, Europe, 2019 – 2029 | 257 |
Figure 7‑15: Covered Stent Procedures by Country, Europe, 2019 – 2029 | 258 |
Figure 7‑16: Iliac Covered Stent Procedures by Country, Europe, 2019 – 2029 | 259 |
Figure 7‑17: Fem-Pop Covered Stent Procedures by Country, Europe, 2019 – 2029 | 260 |
Figure 7‑18: AV Access Covered Stent Procedures by Country, Europe, 2019 – 2029 | 261 |
Figure 7‑19: Drug-Eluting Stent Procedures by Indication, Europe, 2019 – 2029 | 262 |
Figure 7‑20: Drug-Eluting Stent Procedures by Country, Europe, 2019 – 2029 | 263 |
Figure 7‑21: SFA Drug-Eluting Stent Procedures by Country, Europe, 2019 – 2029 | 264 |
Figure 7‑22: Infra-Pop Drug-Eluting Stent Procedures by Country, Europe, 2019 – 2029 | 265 |
Figure 7‑23: Venous Stent Procedures by Country, Europe, 2019 – 2029 | 267 |
Figure 7‑24: PTA Balloon Catheter Procedures by Country, Europe, 2019 – 2029 | 269 |
Figure 7‑25: Drug-Coated Balloon Procedures by Country, Europe, 2019 – 2029 | 271 |
Figure 7‑26: Atherectomy Device Procedures by Device Type, Europe, 2019 – 2029 | 272 |
Figure 7‑27: Atherectomy Device Procedures by Country, Europe, 2019 – 2029 | 273 |
Figure 7‑28: Laser Atherectomy Device Procedures by Country, Europe, 2019 – 2029 | 274 |
Figure 7‑29: Mechanical Atherectomy Device Procedures by Country, Europe, 2019 – 2029 | 275 |
Figure 7‑30: Intravascular Lithotripsy Procedures by Device Type, Europe, 2019 – 2029 | 277 |
Figure 7‑31: Intravascular Lithotripsy Procedures by Country, Europe, 2019 – 2029 | 278 |
Figure 7‑32: SFA and Iliac Lithotripsy Procedures by Country, Europe, 2019 – 2029 | 279 |
Figure 7‑33: BTK Lithotripsy Procedures by Country, Europe, 2019 – 2029 | 280 |
Figure 7‑34: CTO Device Procedures by Device Type, Europe, 2019 – 2029 | 281 |
Figure 7‑35: CTO Device Procedures by Country, Europe, 2019 – 2029 | 282 |
Figure 7‑36: Re-Entry CTO Procedures by Country, Europe, 2019 – 2029 | 283 |
Figure 7‑37: Recanalization CTO Procedures by Country, Europe, 2019 – 2029 | 284 |
Figure 7‑38: Total Surgical Graft Procedures by Material, Europe, 2019 – 2029 | 286 |
Figure 7‑39: Total Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 287 |
Figure 7‑40: Polyester Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 288 |
Figure 7‑41: ePTFE Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 289 |
Figure 7‑42: Total Surgical Graft Procedures by Indication, Europe, 2019 – 2029 | 290 |
Figure 7‑43: Lower-Limb Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 291 |
Figure 7‑44: Above-the-Knee Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 292 |
Figure 7‑45: Below-the-Knee Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 293 |
Figure 7‑46: AV Access Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 294 |
Figure 7‑47: Aorta Repair Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 295 |
Figure 7‑48: Abdominal Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 296 |
Figure 7‑49: Thoracic Aortic Aneurysm Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 297 |
Figure 7‑50: Extra-Anatomical Bypass Surgical Graft Procedures by Country, Europe, 2019 – 2029 | 298 |
Figure 7‑51: Stent Graft Procedures by Device Type, Europe, 2019 – 2029 | 299 |
Figure 7‑52: Stent Graft Procedures by Country, Europe, 2019 – 2029 | 300 |
Figure 7‑53: AAA Stent Graft Procedures by Country, Europe, 2019 – 2029 | 301 |
Figure 7‑54: Fenestrated Stent Graft Procedures by Country, Europe, 2019 – 2029 | 302 |
Figure 7‑55: TAA Stent Graft Procedures by Country, Europe, 2019 – 2029 | 303 |
Figure 7‑56: Embolic Protection Device Procedures by Device Type, Europe, 2019 – 2029 | 304 |
Figure 7‑57: Embolic Protection Device Procedures by Country, Europe, 2019 – 2029 | 305 |
Figure 7‑58: Carotid EPD Procedures by Country, Europe, 2019 – 2029 | 306 |
Figure 7‑59: Renal EPD Procedures by Country, Europe, 2019 – 2029 | 307 |
Figure 7‑60: Lower-Limb EPD Procedures by Country, Europe, 2019 – 2029 | 308 |
Figure 7‑61: Peripheral Thrombus Management Procedures by Device Type, Europe, 2019 – 2029 | 309 |
Figure 7‑62: Peripheral Thrombus Management Procedures by Country, Europe, 2019 – 2029 | 310 |
Figure 7‑63: Traditional Thrombectomy Device Procedures by Country, Europe, 2019 – 2029 | 311 |
Figure 7‑64: Pharmacomechanical Thrombectomy Device Procedures by Country, Europe, 2019 – 2029 | 312 |
Figure 7‑65 IVCF Placement Procedures by Device Type, Europe, 2019 – 2029 | 314 |
Figure 7‑66 IVCF Placement Procedures by Country, Europe, 2019 – 2029 | 315 |
Figure 7‑67: Retrievable IVCF Procedures by Country, Europe, 2019 – 2029 | 316 |
Figure 7‑68: Permanent IVCF Procedures by Country, Europe, 2019 – 2029 | 317 |
Figure 7‑69: Carotid Shunt Procedures by Country, Europe, 2019 – 2029 | 319 |
Figure 7‑70: Total Vascular Closure Device Procedures by Device Type, Europe, 2019 – 2029 | 321 |
Figure 7‑71: Total Vascular Closure Device Procedures by Country, Europe, 2019 – 2029 | 322 |
Figure 7‑72: Small-Bore Invasive VCD Procedures by Country, Europe, 2019 – 2029 | 323 |
Figure 7‑73: Large-Bore Invasive VCD Procedures by Country, Europe, 2019 – 2029 | 324 |
Figure 7‑74: Non-Invasive VCD Procedures by Country, Europe, 2019 – 2029 | 325 |
Figure 7‑75: Total VCD Procedures by Approach, Europe, 2019 – 2029 | 326 |
Figure 7‑76: Radial VCD Procedures by Country, Europe, 2019 – 2029 | 327 |
Figure 7‑77: Femoral VCD Procedures by Country, Europe, 2019 – 2029 | 328 |
Figure 7‑78: Transcatheter Embolization Procedures by Device Type, Europe, 2019 – 2029 | 330 |
Figure 7‑79: Transcatheter Embolization Procedures by Country, Europe, 2019 – 2029 | 331 |
Figure 7‑80: Particle Embolization Procedures by Device Type, Europe, 2019 – 2029 | 332 |
Figure 7‑81: Particle Embolization Procedures by Country, Europe, 2019 – 2029 | 333 |
Figure 7‑82: PVA Particle Procedures by Country, Europe, 2019 – 2029 | 334 |
Figure 7‑83: Microsphere Procedures by Country, Europe, 2019 – 2029 | 335 |
Figure 7‑84: Drug-Eluting Particle Procedures by Country, Europe, 2019 – 2029 | 336 |
Figure 7‑85: Radioactive Particle Procedures by Country, Europe, 2019 – 2029 | 337 |
Figure 7‑86: Coil Embolization Procedures by Device Type, Europe, 2019 – 2029 | 338 |
Figure 7‑87: Coil Embolization Procedures by Country, Europe, 2019 – 2029 | 339 |
Figure 7‑88: Pushable Coil Procedures by Country, Europe, 2019 – 2029 | 340 |
Figure 7‑89: Detachable Coil Procedures by Country, Europe, 2019 – 2029 | 341 |
Figure 7‑90: Liquid Embolics Procedures by Country, Europe, 2019 – 2029 | 342 |
Figure 7‑91: Plug Embolization Procedures by Country, Europe, 2019 – 2029 | 343 |
Figure 7‑92: Peripheral IVUS Procedures by Country, Europe, 2019 – 2029 | 345 |
Figure 8‑1: Peripheral Vascular Stent Market by Segment, Europe, 2019 – 2029 (€M) | 353 |
Figure 8‑2: Peripheral Vascular Stent Market by Segment, Europe, 2019 – 2029 (US$M) | 353 |
Figure 8‑3: Arterial Stent Market by Device Type, Europe, 2019 – 2029 (€M) | 356 |
Figure 8‑4: Arterial Stent Market by Device Type, Europe, 2019 – 2029 (US$M) | 356 |
Figure 8‑5: Arterial Stent Market, Europe, 2019 – 2029 | 357 |
Figure 8‑6: Units Sold by Country, Arterial Stent Market, Europe, 2019 – 2029 | 358 |
Figure 8‑7: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 – 2029 (€) | 359 |
Figure 8‑8: Average Selling Price by Country, Arterial Stent Market, Europe, 2019 – 2029 (US$) | 360 |
Figure 8‑9: Market Value by Country, Arterial Stent Market, Europe, 2019 – 2029 (€M) | 361 |
Figure 8‑10: Market Value by Country, Arterial Stent Market, Europe, 2019 – 2029 (US$M) | 362 |
Figure 8‑11: Bare-Metal Stent Market by Indication, Europe, 2019 – 2029 (€M) | 364 |
Figure 8‑12: Bare-Metal Stent Market by Indication, Europe, 2019 – 2029 (US$M) | 365 |
Figure 8‑13: Total Bare-Metal Stent Market, Europe, 2019 – 2029 | 365 |
Figure 8‑14: Units Sold by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 | 366 |
Figure 8‑15: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (€) | 367 |
Figure 8‑16: Average Selling Price by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (US$) | 368 |
Figure 8‑17: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (€M) | 369 |
Figure 8‑18: Market Value by Country, Total Bare-Metal Stent Market, Europe, 2019 – 2029 (US$M) | 370 |
Figure 8‑19: Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 | 371 |
Figure 8‑20: Units Sold by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 | 372 |
Figure 8‑21: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (€) | 373 |
Figure 8‑22: Average Selling Price by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (US$) | 374 |
Figure 8‑23: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (€M) | 375 |
Figure 8‑24: Market Value by Country, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 (US$M) | 376 |
Figure 8‑25: Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 | 377 |
Figure 8‑26: Units Sold by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 | 378 |
Figure 8‑27: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (€) | 379 |
Figure 8‑28: Average Selling Price by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (US$) | 380 |
Figure 8‑29: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (€M) | 381 |
Figure 8‑30: Market Value by Country, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 (US$M) | 382 |
Figure 8‑31: Bare-Metal Renal Stent Market, Europe, 2019 – 2029 | 383 |
Figure 8‑32: Units Sold by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 | 384 |
Figure 8‑33: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (€) | 385 |
Figure 8‑34: Average Selling Price by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (US$) | 386 |
Figure 8‑35: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (€M) | 387 |
Figure 8‑36: Market Value by Country, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 (US$M) | 388 |
Figure 8‑37: Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 | 389 |
Figure 8‑38: Units Sold by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 | 390 |
Figure 8‑39: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (€) | 391 |
Figure 8‑40: Average Selling Price by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (US$) | 392 |
Figure 8‑41: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (€M) | 393 |
Figure 8‑42: Market Value by Country, Bare-Metal Fem-Pop Stent Market, Europe, 2019 – 2029 (US$M) | 394 |
Figure 8‑43: Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 | 395 |
Figure 8‑44: Units Sold by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 | 396 |
Figure 8‑45: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (€) | 397 |
Figure 8‑46: Average Selling Price by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (US$) | 398 |
Figure 8‑47: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (€M) | 399 |
Figure 8‑48: Market Value by Country, Bare-Metal Infra-Pop Stent Market, Europe, 2019 – 2029 (US$M) | 400 |
Figure 8‑49: Covered Stent Market, Europe, 2019 – 2029 | 401 |
Figure 8‑50: Units Sold by Country, Covered Stent Market, Europe, 2019 – 2029 | 402 |
Figure 8‑51: Average Selling Price by Country, Covered Stent Market, Europe, 2019 – 2029 (€) | 403 |
Figure 8‑52: Average Selling Price by Country, Covered Stent Market, Europe, 2019 – 2029 (US$) | 404 |
Figure 8‑53: Market Value by Country, Covered Stent Market, Europe, 2019 – 2029 (€M) | 405 |
Figure 8‑54: Market Value by Country, Covered Stent Market, Europe, 2019 – 2029 (US$M) | 406 |
Figure 8‑55: Drug-Eluting Stent Market, Europe, 2019 – 2029 | 408 |
Figure 8‑56: Units Sold by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 | 409 |
Figure 8‑57: Average Selling Price by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (€) | 410 |
Figure 8‑58: Average Selling Price by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (US$) | 411 |
Figure 8‑59: Market Value by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (€M) | 412 |
Figure 8‑60: Market Value by Country, Drug-Eluting Stent Market, Europe, 2019 – 2029 (US$M) | 413 |
Figure 8‑61: Venous Stent Market, Europe, 2019 – 2029 | 415 |
Figure 8‑62: Units Sold by Country, Venous Stent Market, Europe, 2019 – 2029 | 416 |
Figure 8‑63: Average Selling Price by Country, Venous Stent Market, Europe, 2019 – 2029 (€) | 417 |
Figure 8‑64: Average Selling Price by Country, Venous Stent Market, Europe, 2019 – 2029 (US$) | 418 |
Figure 8‑65: Market Value by Country, Venous Stent Market, Europe, 2019 – 2029 (€M) | 419 |
Figure 8‑66: Market Value by Country, Venous Stent Market, Europe, 2019 – 2029 (US$M) | 420 |
Figure 8‑67: Units Sold by Delivery Platform, Bare-Metal Stent Market, Europe, 2019 – 2029 | 421 |
Figure 8‑68: Units Sold by Country, Self-Expanding Bare-Metal Stent Market, Europe, 2019 – 2029 | 422 |
Figure 8‑69: Units Sold by Country, Balloon-Expanding Bare-Metal Stent Market, Europe, 2019 – 2029 | 423 |
Figure 8‑70: Units Sold by Stent Length, Bare-Metal Stent Market, Europe, 2019 – 2029 | 425 |
Figure 8‑71: Units Sold by Stent Length, Bare-Metal Carotid Stent Market, Europe, 2019 – 2029 | 426 |
Figure 8‑72: Units Sold by Stent Length, Bare-Metal Iliac Stent Market, Europe, 2019 – 2029 | 427 |
Figure 8‑73: Units Sold by Stent Length, Bare-Metal Renal Stent Market, Europe, 2019 – 2029 | 428 |
Figure 8‑74: Units Sold by Stent Length, Bare-Metal Fem-Popliteal Stent Market, Europe, 2019 – 2029 | 429 |
Figure 8‑75: Units Sold by Delivery Platform, Covered Stent Market, Europe, 2019 – 2029 | 430 |
Figure 8‑76: Units Sold by Country, Iliac Covered Stent Market, Europe, 2019 – 2029 | 431 |
Figure 8‑77: Units Sold by Country, Fem-Pop Covered Stent Market, Europe, 2019 – 2029 | 432 |
Figure 8‑78: Units Sold by Country, AV Access Covered Stent Market, Europe, 2019 – 2029 | 433 |
Figure 8‑79: Units Sold by Delivery Platform, Drug-Eluting Stent Market, Europe, 2019 – 2029 | 434 |
Figure 8‑80: Units Sold by Country, SFA Drug-Eluting Stent Market, Europe, 2019 – 2029 | 435 |
Figure 8‑81: Units Sold by Country, Infra-Pop Drug-Eluting Stent Market, Europe, 2019 – 2029 | 436 |
Figure 8‑82: Leading Competitors, Peripheral Vascular Stent Market, Europe, 2022 | 445 |
Figure 9‑1: PTA Balloon Catheter Market by Segment, Europe, 2019 – 2029 (€M) | 450 |
Figure 9‑2: PTA Balloon Catheter Market by Segment, Europe, 2019 – 2029 (US$M) | 451 |
Figure 9‑3: Total PTA Balloon Catheter Market, Europe, 2019 – 2029 | 453 |
Figure 9‑4: Units Sold by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 | 454 |
Figure 9‑5: Average Selling Price by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (€) | 455 |
Figure 9‑6: Average Selling Price by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$) | 456 |
Figure 9‑7: Market Value by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M) | 457 |
Figure 9‑8: Market Value by Country, PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) | 458 |
Figure 9‑9: Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 | 459 |
Figure 9‑10: Units Sold by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 | 460 |
Figure 9‑11: Average Selling Price by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (€) | 461 |
Figure 9‑12: Average Selling Price by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$) | 462 |
Figure 9‑13: Market Value by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M) | 463 |
Figure 9‑14: Market Value by Country, Standard PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) | 464 |
Figure 9‑15: High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 | 465 |
Figure 9‑16: Units Sold by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 | 466 |
Figure 9‑17: Average Selling Price by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (€) | 467 |
Figure 9‑18: Average Selling Price by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$) | 468 |
Figure 9‑19: Market Value by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M) | 469 |
Figure 9‑20: Market Value by Country, High-Pressure PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) | 470 |
Figure 9‑21: Large PTA Balloon Catheter Market, Europe, 2019 – 2029 | 471 |
Figure 9‑22: Units Sold by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 | 472 |
Figure 9‑23: Average Selling Price by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (€) | 473 |
Figure 9‑24: Average Selling Price by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$) | 474 |
Figure 9‑25: Market Value by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M) | 475 |
Figure 9‑26: Market Value by Country, Large PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) | 476 |
Figure 9‑27: Small PTA Balloon Catheter Market, Europe, 2019 – 2029 | 477 |
Figure 9‑28: Units Sold by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 | 478 |
Figure 9‑29: Average Selling Price by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (€) | 479 |
Figure 9‑30: Average Selling Price by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$) | 480 |
Figure 9‑31: Market Value by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M) | 481 |
Figure 9‑32: Market Value by Country, Small PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) | 482 |
Figure 9‑33: Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 | 483 |
Figure 9‑34: Units Sold by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 | 484 |
Figure 9‑35: Average Selling Price by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (€) | 485 |
Figure 9‑36: Average Selling Price by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$) | 486 |
Figure 9‑37: Market Value by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (€M) | 487 |
Figure 9‑38: Market Value by Country, Specialty PTA Balloon Catheter Market, Europe, 2019 – 2029 (US$M) | 488 |
Figure 9‑39: Leading Competitors by Country, PTA Balloon Catheter Market, Europe, 2022 | 494 |
Figure 10‑1: Drug-Coated Balloon Market, Europe, 2019 – 2029 | 499 |
Figure 10‑2: Units Sold by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 | 501 |
Figure 10‑3: Average Selling Price by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (€) | 502 |
Figure 10‑4: Average Selling Price by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (US$) | 503 |
Figure 10‑5: Market Value by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (€M) | 504 |
Figure 10‑6: Market Value by Country, Drug-Coated Balloon Market, Europe, 2019 – 2029 (US$M) | 505 |
Figure 10‑7: Leading Competitors, Drug-Coated Balloon Market, Europe, 2022 | 510 |
Figure 11‑1: Atherectomy Device Market by Segment, Europe, 2019 – 2029 (€M) | 515 |
Figure 11‑2: Atherectomy Device Market by Segment, Europe, 2019 – 2029 (US$M) | 515 |
Figure 11‑3: Total Atherectomy Device Market, Europe, 2019 – 2029 | 518 |
Figure 11‑4: Units Sold by Country, Atherectomy Device Market, Europe, 2019 – 2029 | 519 |
Figure 11‑5: Average Selling Price by Country, Atherectomy Device Market, Europe, 2019 – 2029 (€) | 520 |
Figure 11‑6: Average Selling Price by Country, Atherectomy Device Market, Europe, 2019 – 2029 (US$) | 521 |
Figure 11‑7: Market Value by Country, Atherectomy Device Market, Europe, 2019 – 2029 (€M) | 522 |
Figure 11‑8: Market Value by Country, Atherectomy Device Market, Europe, 2019 – 2029 (US$M) | 523 |
Figure 11‑9: Laser Atherectomy Device Market, Europe, 2019 – 2029 | 524 |
Figure 11‑10: Units Sold by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 | 525 |
Figure 11‑11: Average Selling Price by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (€) | 526 |
Figure 11‑12: Average Selling Price by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (US$) | 527 |
Figure 11‑13: Market Value by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (€M) | 528 |
Figure 11‑14: Market Value by Country, Laser Atherectomy Device Market, Europe, 2019 – 2029 (US$M) | 529 |
Figure 11‑15: Mechanical Atherectomy Device Market, Europe, 2019 – 2029 | 530 |
Figure 11‑16: Units Sold by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 | 531 |
Figure 11‑17: Average Selling Price by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (€) | 532 |
Figure 11‑18: Average Selling Price by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (US$) | 533 |
Figure 11‑19: Market Value by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (€M) | 534 |
Figure 11‑20: Market Value by Country, Mechanical Atherectomy Device Market, Europe, 2019 – 2029 (US$M) | 535 |
Figure 11‑21: Leading Competitors, Atherectomy Device Market, Europe, 2022 | 541 |
Figure 12‑1: Intravascular Lithotripsy Market, Europe, 2019 – 2029 | 545 |
Figure 12‑2: Units Sold by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 | 547 |
Figure 12‑3: Average Selling Price by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (€) | 548 |
Figure 12‑4: Average Selling Price by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (US$) | 549 |
Figure 12‑5: Market Value by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (€M) | 550 |
Figure 12‑6: Market Value by Country, Intravascular Lithotripsy Market, Europe, 2019 – 2029 (US$M) | 551 |
Figure 12‑7: Leading Competitors, Intravascular Lithotripsy Market, Europe, 2022 | 554 |
Figure 13‑1: CTO Device Market by Segment, Europe, 2019 – 2029 (€M) | 556 |
Figure 13‑2: CTO Device Market by Segment, Europe, 2019 – 2029 (US$M) | 557 |
Figure 13‑3: Total CTO Device Market, Europe, 2019 – 2029 | 559 |
Figure 13‑4: Units Sold by Country, CTO Device Market, Europe, 2019 – 2029 | 560 |
Figure 13‑5: Average Selling Price by Country, CTO Device Market, Europe, 2019 – 2029 (€) | 561 |
Figure 13‑6: Average Selling Price by Country, CTO Device Market, Europe, 2019 – 2029 (US$) | 562 |
Figure 13‑7: Market Value by Country, CTO Device Market, Europe, 2019 – 2029 (€M) | 563 |
Figure 13‑8: Market Value by Country, CTO Device Market, Europe, 2019 – 2029 (US$M) | 564 |
Figure 13‑9: Re-Entry Device Market, Europe, 2019 – 2029 | 565 |
Figure 13‑10: Units Sold by Country, Re-Entry Device Market, Europe, 2019 – 2029 | 566 |
Figure 13‑11: Average Selling Price by Country, Re-Entry Device Market, Europe, 2019 – 2029 (€) | 567 |
Figure 13‑12: Average Selling Price by Country, Re-Entry Device Market, Europe, 2019 – 2029 (US$) | 568 |
Figure 13‑13: Market Value by Country, Re-Entry Device Market, Europe, 2019 – 2029 (€M) | 569 |
Figure 13‑14: Market Value by Country, Re-Entry Device Market, Europe, 2019 – 2029 (US$M) | 570 |
Figure 13‑15: Recanalization Device Market, Europe, 2019 – 2029 | 571 |
Figure 13‑16: Units Sold by Country, Recanalization Device Market, Europe, 2019 – 2029 | 572 |
Figure 13‑17: Average Selling Price by Country, Recanalization Device Market, Europe, 2019 – 2029 (€) | 573 |
Figure 13‑18: Average Selling Price by Country, Recanalization Device Market, Europe, 2019 – 2029 (US$) | 574 |
Figure 13‑19: Market Value by Country, Recanalization Device Market, Europe, 2019 – 2029 (€M) | 575 |
Figure 13‑20: Market Value by Country, Recanalization Device Market, Europe, 2019 – 2029 (US$M) | 576 |
Figure 13‑21: Leading Competitors, CTO Device Market, Europe, 2022 | 580 |
Figure 14‑1: Surgical Graft Market by Segment, Europe, 2019 – 2029 (€M) | 583 |
Figure 14‑2: Surgical Graft Market by Segment, Europe, 2019 – 2029 (US$M) | 584 |
Figure 14‑3: Total Lower-Limb Surgical Graft Market by Segment, Europe, 2019 – 2029 (€M) | 587 |
Figure 14‑4: Lower-Limb Surgical Graft Market by Segment, Europe, 2019 – 2029 (US$M) | 588 |
Figure 14‑5: Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 | 588 |
Figure 14‑6: Units Sold by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 | 589 |
Figure 14‑7: Average Selling Price by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (€) | 590 |
Figure 14‑8: Average Selling Price by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (US$) | 591 |
Figure 14‑9: Market Value by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (€M) | 592 |
Figure 14‑10: Market Value by Country, Total Lower-Limb Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 593 |
Figure 14‑11: Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 | 594 |
Figure 14‑12: Units Sold by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 | 595 |
Figure 14‑13: Average Selling Price by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€) | 596 |
Figure 14‑14: Average Selling Price by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$) | 597 |
Figure 14‑15: Market Value by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€M) | 598 |
Figure 14‑16: Market Value by Country, Above-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 599 |
Figure 14‑17: Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 | 600 |
Figure 14‑18: Units Sold by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 | 601 |
Figure 14‑19: Average Selling Price by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€) | 602 |
Figure 14‑20: Average Selling Price by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$) | 603 |
Figure 14‑21: Market Value by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (€M) | 604 |
Figure 14‑22: Market Value by Country, Below-the-Knee Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 605 |
Figure 14‑23: AV Access Surgical Graft Market, Europe, 2019 – 2029 | 606 |
Figure 14‑24: Units Sold by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 | 607 |
Figure 14‑25: Average Selling Price by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (€) | 608 |
Figure 14‑26: Average Selling Price by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (US$) | 609 |
Figure 14‑27: Market Value by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (€M) | 610 |
Figure 14‑28: Market Value by Country, AV Access Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 611 |
Figure 14‑29: Total Aorta Repair Surgical Graft Market by Segment, Europe, 2019 – 2029 (€M) | 612 |
Figure 14‑30: Aorta Repair Surgical Graft Market by Segment, Europe, 2019 – 2029 (US$M) | 613 |
Figure 14‑31: Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 | 614 |
Figure 14‑32: Units Sold by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 | 615 |
Figure 14‑33: Average Selling Price by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (€) | 616 |
Figure 14‑34: Average Selling Price by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (US$) | 617 |
Figure 14‑35: Market Value by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (€M) | 618 |
Figure 14‑36: Market Value by Country, Total Aorta Repair Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 619 |
Figure 14‑37: Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 | 620 |
Figure 14‑38: Units Sold by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 | 621 |
Figure 14‑39: Average Selling Price by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€) | 622 |
Figure 14‑40: Average Selling Price by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$) | 623 |
Figure 14‑41: Market Value by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€M) | 624 |
Figure 14‑42: Market Value by Country, Abdominal Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 625 |
Figure 14‑43: Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 | 626 |
Figure 14‑44: Units Sold by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 | 627 |
Figure 14‑45: Average Selling Price by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€) | 628 |
Figure 14‑46: Average Selling Price by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$) | 629 |
Figure 14‑47: Market Value by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (€M) | 630 |
Figure 14‑48: Market Value by Country, Thoracic Aortic Aneurysm Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 631 |
Figure 14‑49: Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 | 632 |
Figure 14‑50: Units Sold by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 | 633 |
Figure 14‑51: Average Selling Price by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (€) | 634 |
Figure 14‑52: Average Selling Price by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (US$) | 635 |
Figure 14‑53: Market Value by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (€M) | 636 |
Figure 14‑54: Market Value by Country, Extra-Anatomical Bypass Surgical Graft Market, Europe, 2019 – 2029 (US$M) | 637 |
Figure 14‑55: Units Sold by Material, Surgical Graft Market, Europe, 2019 – 2029 | 638 |
Figure 14‑56: Units Sold by Country, Polyester Surgical Graft Market, Europe, 2019 – 2029 | 639 |
Figure 14‑57: Units Sold by Country, ePTFE Surgical Graft Market, Europe, 2019 – 2029 | 640 |
Figure 14‑58: Leading Competitors, Surgical Graft Market, Europe, 2022 | 645 |
Figure 15‑1: Stent Graft Market by Segment, Europe, 2019 – 2029 (€M) | 648 |
Figure 15‑2: Stent Graft Market by Segment, Europe, 2019 – 2029 (US$M) | 649 |
Figure 15‑3: Total Stent Graft Market, Europe, 2019 – 2029 | 652 |
Figure 15‑4: Units Sold by Country, Stent Graft Market, Europe, 2019 – 2029 | 653 |
Figure 15‑5: Average Selling Price by Country, Stent Graft Market, Europe, 2019 – 2029 (€) | 654 |
Figure 15‑6: Average Selling Price by Country, Stent Graft Market, Europe, 2019 – 2029 (US$) | 655 |
Figure 15‑7: Market Value by Country, Stent Graft Market, Europe, 2019 – 2029 (€M) | 656 |
Figure 15‑8: Market Value by Country, Stent Graft Market, Europe, 2019 – 2029 (US$M) | 657 |
Figure 15‑9: AAA Stent Graft Market, Europe, 2019 – 2029 | 658 |
Figure 15‑10: Units Sold by Country, AAA Stent Graft Market, Europe, 2019 – 2029 | 659 |
Figure 15‑11: Average Selling Price by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (€) | 660 |
Figure 15‑12: Average Selling Price by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (US$) | 661 |
Figure 15‑13: Market Value by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (€M) | 662 |
Figure 15‑14: Market Value by Country, AAA Stent Graft Market, Europe, 2019 – 2029 (US$M) | 663 |
Figure 15‑15: TAA Stent Graft Market, Europe, 2019 – 2029 | 664 |
Figure 15‑16: Units Sold by Country, TAA Stent Graft Market, Europe, 2019 – 2029 | 665 |
Figure 15‑17: Average Selling Price by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (€) | 666 |
Figure 15‑18: Average Selling Price by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (US$) | 667 |
Figure 15‑19: Market Value by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (€M) | 668 |
Figure 15‑20: Market Value by Country, TAA Stent Graft Market, Europe, 2019 – 2029 (US$M) | 669 |
Figure 15‑21: Fenestrated Stent Graft Market, Europe, 2019 – 2029 | 671 |
Figure 15‑22: Units Sold by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 | 672 |
Figure 15‑23: Average Selling Price by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (€) | 673 |
Figure 15‑24: Average Selling Price by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (US$) | 674 |
Figure 15‑25: Market Value by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (€M) | 675 |
Figure 15‑26: Market Value by Country, Fenestrated Stent Graft Market, Europe, 2019 – 2029 (US$M) | 676 |
Figure 15‑27: Leading Competitors, Stent Graft Market, Europe, 2022 | 682 |
Figure 16‑1: Embolic Protection Device Market by Segment, Europe, 2019 – 2029 (€M) | 686 |
Figure 16‑2: Embolic Protection Device Market by Segment, Europe, 2019 – 2029 (US$M) | 687 |
Figure 16‑3: Total Embolic Protection Device Market, Europe, 2019 – 2029 | 689 |
Figure 16‑4: Units Sold by Country, Embolic Protection Device Market, Europe, 2019 – 2029 | 690 |
Figure 16‑5: Average Selling Price by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (€) | 691 |
Figure 16‑6: Average Selling Price by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (US$) | 692 |
Figure 16‑7: Market Value by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (€M) | 693 |
Figure 16‑8: Market Value by Country, Embolic Protection Device Market, Europe, 2019 – 2029 (US$M) | 694 |
Figure 16‑9: Carotid Embolic Protection Device Market, Europe, 2019 – 2029 | 695 |
Figure 16‑10: Units Sold by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 | 696 |
Figure 16‑11: Average Selling Price by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (€) | 697 |
Figure 16‑12: Average Selling Price by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (US$) | 698 |
Figure 16‑13: Market Value by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (€M) | 699 |
Figure 16‑14: Market Value by Country, Carotid Embolic Protection Device Market, Europe, 2019 – 2029 (US$M) | 700 |
Figure 16‑15: Renal Embolic Protection Device Market, Europe, 2019 – 2029 | 701 |
Figure 16‑16: Units Sold by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 | 702 |
Figure 16‑17: Average Selling Price by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (€) | 703 |
Figure 16‑18: Average Selling Price by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (US$) | 704 |
Figure 16‑19: Market Value by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (€M) | 705 |
Figure 16‑20: Market Value by Country, Renal Embolic Protection Device Market, Europe, 2019 – 2029 (US$M) | 706 |
Figure 16‑21: Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 | 707 |
Figure 16‑22: Units Sold by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 | 708 |
Figure 16‑23: Average Selling Price by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (€) | 709 |
Figure 16‑24: Average Selling Price by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (US$) | 710 |
Figure 16‑25: Market Value by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (€M) | 711 |
Figure 16‑26: Market Value by Country, Lower-Limb Embolic Protection Device Market, Europe, 2019 – 2029 (US$M) | 712 |
Figure 16‑27: Leading Competitors, Embolic Protection Device Market, Europe, 2022 | 716 |
Figure 17‑1: Peripheral Thrombus Management Market by Segment, Europe, 2019 – 2029 (€M) | 721 |
Figure 17‑2: Peripheral Thrombus Management Market by Segment, Europe, 2019 – 2029 (US$M) | 721 |
Figure 17‑3: Total Peripheral Thrombus Management Market, Europe, 2019 – 2029 | 723 |
Figure 17‑4: Units Sold by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 | 724 |
Figure 17‑5: Average Selling Price by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (€) | 725 |
Figure 17‑6: Average Selling Price by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (US$) | 726 |
Figure 17‑7: Market Value by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (€M) | 727 |
Figure 17‑8: Market Value by Country, Peripheral Thrombus Management Market, Europe, 2019 – 2029 (US$M) | 728 |
Figure 17‑9: Traditional Thrombectomy Device Market, Europe, 2019 – 2029 | 729 |
Figure 17‑10: Units Sold by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 | 730 |
Figure 17‑11: Average Selling Price by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (€) | 731 |
Figure 17‑12: Average Selling Price by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (US$) | 732 |
Figure 17‑13: Market Value by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (€M) | 733 |
Figure 17‑14: Market Value by Country, Traditional Thrombectomy Device Market, Europe, 2019 – 2029 (US$M) | 734 |
Figure 17‑15: Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 | 736 |
Figure 17‑16: Units Sold by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 | 737 |
Figure 17‑17: Average Selling Price by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (€) | 738 |
Figure 17‑18: Average Selling Price by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (US$) | 739 |
Figure 17‑19: Market Value by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (€M) | 740 |
Figure 17‑20: Market Value by Country, Pharmacomechanical Thrombectomy Device Market, Europe, 2019 – 2029 (US$M) | 741 |
Figure 17‑21: Leading Competitors, Peripheral Thrombus Management Market, Europe, 2022 | 745 |
Figure 18‑1: Inferior Vena Cava Filter Market by Segment, Europe, 2019 – 2029 (€M) | 749 |
Figure 18‑2: Inferior Vena Cava Filter Market by Segment, Europe, 2019 – 2029 (US$M) | 750 |
Figure 18‑3: Total Inferior Vena Cava Filter Market, Europe, 2019 – 2029 | 753 |
Figure 18‑4: Units Sold by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 | 754 |
Figure 18‑5: Average Selling Price by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (€) | 755 |
Figure 18‑6: Average Selling Price by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (US$) | 756 |
Figure 18‑7: Market Value by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (€M) | 757 |
Figure 18‑8: Market Value by Country, Inferior Vena Cava Filter Market, Europe, 2019 – 2029 (US$M) | 758 |
Figure 18‑9: Retrievable IVCF Market, Europe, 2019 – 2029 | 759 |
Figure 18‑10: Units Sold by Country, Retrievable IVCF Market, Europe, 2019 – 2029 | 760 |
Figure 18‑11: Average Selling Price by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (€) | 761 |
Figure 18‑12: Average Selling Price by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (US$) | 762 |
Figure 18‑13: Market Value by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (€M) | 763 |
Figure 18‑14: Market Value by Country, Retrievable IVCF Market, Europe, 2019 – 2029 (US$M) | 764 |
Figure 18‑15: Permanent IVCF Market, Europe, 2019 – 2029 | 765 |
Figure 18‑16: Units Sold by Country, Permanent IVCF Market, Europe, 2019 – 2029 | 766 |
Figure 18‑17: Average Selling Price by Country, Permanent IVCF Market, Europe, 2019 – 2029 (€) | 767 |
Figure 18‑18: Average Selling Price by Country, Permanent IVCF Market, Europe, 2019 – 2029 (US$) | 768 |
Figure 18‑19: Market Value by Country, Permanent IVCF Market, Europe, 2019 – 2029 (€M) | 769 |
Figure 18‑20: Market Value by Country, Permanent IVCF Market, Europe, 2019 – 2029 (US$M) | 770 |
Figure 18‑21: Leading Competitors, Inferior Vena Cava Filter Market, Europe, 2022 | 775 |
Figure 19‑1: Carotid Shunt Market, Europe, 2019 – 2029 | 778 |
Figure 19‑2: Units Sold by Country, Carotid Shunt Market, Europe, 2019 – 2029 | 780 |
Figure 19‑3: Average Selling Price by Country, Carotid Shunt Market, Europe, 2019 – 2029 (€) | 781 |
Figure 19‑4: Average Selling Price by Country, Carotid Shunt Market, Europe, 2019 – 2029 (US$) | 782 |
Figure 19‑5: Market Value by Country, Carotid Shunt Market, Europe, 2019 – 2029 (€M) | 783 |
Figure 19‑6: Market Value by Country, Carotid Shunt Market, Europe, 2019 – 2029 (US$M) | 784 |
Figure 19‑7: Leading Competitors, Carotid Shunt Market, Europe, 2022 | 787 |
Figure 20‑1: Diagnostic and Interventional Catheter Market by Segment, Europe, 2019 – 2029 (€M) | 790 |
Figure 20‑2: Diagnostic and Interventional Catheter Market by Segment, Europe, 2019 – 2029 (US$M) | 791 |
Figure 20‑3: Total Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 | 793 |
Figure 20‑4: Units Sold by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 | 794 |
Figure 20‑5: Average Selling Price by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (€) | 795 |
Figure 20‑6: Average Selling Price by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (US$) | 796 |
Figure 20‑7: Market Value by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (€M) | 797 |
Figure 20‑8: Market Value by Country, Diagnostic and Interventional Catheter Market, Europe, 2019 – 2029 (US$M) | 798 |
Figure 20‑9: Total Diagnostic Catheter Market by Segment, Europe, 2019 – 2029 (€M) | 799 |
Figure 20‑10: Diagnostic Catheter Market by Segment, Europe, 2019 – 2029 (US$M) | 800 |
Figure 20‑11: Total Diagnostic Catheter Market, Europe, 2019 – 2029 | 800 |
Figure 20‑12: Units Sold by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 | 801 |
Figure 20‑13: Average Selling Price by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (€) | 802 |
Figure 20‑14: Average Selling Price by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (US$) | 803 |
Figure 20‑15: Market Value by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (€M) | 804 |
Figure 20‑16: Market Value by Country, Total Diagnostic Catheter Market, Europe, 2019 – 2029 (US$M) | 805 |
Figure 20‑17: Standard Diagnostic Catheter Market, Europe, 2019 – 2029 | 806 |
Figure 20‑18: Units Sold by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 | 807 |
Figure 20‑19: Average Selling Price by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (€) | 808 |
Figure 20‑20: Average Selling Price by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (US$) | 809 |
Figure 20‑21: Market Value by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (€M) | 810 |
Figure 20‑22: Market Value by Country, Standard Diagnostic Catheter Market, Europe, 2019 – 2029 (US$M) | 811 |
Figure 20‑23: Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 | 812 |
Figure 20‑24: Units Sold by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 | 813 |
Figure 20‑25: Average Selling Price by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (€) | 814 |
Figure 20‑26: Average Selling Price by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (US$) | 815 |
Figure 20‑27: Market Value by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (€M) | 816 |
Figure 20‑28: Market Value by Country, Hydrophilic Diagnostic Catheter Market, Europe, 2019 – 2029 (US$M) | 817 |
Figure 20‑29: Support Catheter Market, Europe, 2019 – 2029 | 818 |
Figure 20‑30: Units Sold by Country, Support Catheter Market, Europe, 2019 – 2029 | 819 |
Figure 20‑31: Average Selling Price by Country, Support Catheter Market, Europe, 2019 – 2029 (€) | 820 |
Figure 20‑32: Average Selling Price by Country, Support Catheter Market, Europe, 2019 – 2029 (US$) | 821 |
Figure 20‑33: Market Value by Country, Support Catheter Market, Europe, 2019 – 2029 (€M) | 822 |
Figure 20‑34: Market Value by Country, Support Catheter Market, Europe, 2019 – 2029 (US$M) | 823 |
Figure 20‑35: Leading Competitors, Diagnostic and Interventional Catheter Market, Europe, 2022 | 828 |
Figure 21‑1: Diagnostic and Interventional Guidewire Market by Segment, Europe, 2019 – 2029 (€M) | 831 |
Figure 21‑2: Diagnostic and Interventional Guidewire Market by Segment, Europe, 2019 – 2029 (US$M) | 832 |
Figure 21‑3: Total Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 | 834 |
Figure 21‑4: Units Sold by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 | 835 |
Figure 21‑5: Average Selling Price by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (€) | 836 |
Figure 21‑6: Average Selling Price by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (US$) | 837 |
Figure 21‑7: Market Value by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (€M) | 838 |
Figure 21‑8: Market Value by Country, Diagnostic and Interventional Guidewire Market, Europe, 2019 – 2029 (US$M) | 839 |
Figure 21‑9: Standard Guidewire Market, Europe, 2019 – 2029 | 840 |
Figure 21‑10: Units Sold by Country, Standard Guidewire Market, Europe, 2019 – 2029 | 841 |
Figure 21‑11: Average Selling Price by Country, Standard Guidewire Market, Europe, 2019 – 2029 (€) | 842 |
Figure 21‑12: Average Selling Price by Country, Standard Guidewire Market, Europe, 2019 – 2029 (US$) | 843 |
Figure 21‑13: Market Value by Country, Standard Guidewire Market, Europe, 2019 – 2029 (€M) | 844 |
Figure 21‑14: Market Value by Country, Standard Guidewire Market, Europe, 2019 – 2029 (US$M) | 845 |
Figure 21‑15: Hydrophilic Guidewire Market, Europe, 2019 – 2029 | 846 |
Figure 21‑16: Units Sold by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 | 847 |
Figure 21‑17: Average Selling Price by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (€) | 848 |
Figure 21‑18: Average Selling Price by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (US$) | 849 |
Figure 21‑19: Market Value by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (€M) | 850 |
Figure 21‑20: Market Value by Country, Hydrophilic Guidewire Market, Europe, 2019 – 2029 (US$M) | 851 |
Figure 21‑21: Leading Competitors, Diagnostic and Interventional Guidewire Market, Europe, 2022 | 856 |
Figure 22‑1: Introducer Sheath Market by Segment, Europe, 2019 – 2029 (€M) | 859 |
Figure 22‑2: Introducer Sheath Market by Segment, Europe, 2019 – 2029 (US$M) | 860 |
Figure 22‑3: Total Introducer Sheath Market, Europe, 2019 – 2029 | 862 |
Figure 22‑4: Units Sold by Country, Introducer Sheath Market, Europe, 2019 – 2029 | 863 |
Figure 22‑5: Average Selling Price by Country, Introducer Sheath Market, Europe, 2019 – 2029 (€) | 864 |
Figure 22‑6: Average Selling Price by Country, Introducer Sheath Market, Europe, 2019 – 2029 (US$) | 865 |
Figure 22‑7: Market Value by Country, Introducer Sheath Market, Europe, 2019 – 2029 (€M) | 866 |
Figure 22‑8: Market Value by Country, Introducer Sheath Market, Europe, 2019 – 2029 (US$M) | 867 |
Figure 22‑9: Standard Introducer Sheath Market, Europe, 2019 – 2029 | 868 |
Figure 22‑10: Units Sold by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 | 869 |
Figure 22‑11: Average Selling Price by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (€) | 870 |
Figure 22‑12: Average Selling Price by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (US$) | 871 |
Figure 22‑13: Market Value by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (€M) | 872 |
Figure 22‑14: Market Value by Country, Standard Introducer Sheath Market, Europe, 2019 – 2029 (US$M) | 873 |
Figure 22‑15: Guiding Introducer Sheath Market, Europe, 2019 – 2029 | 874 |
Figure 22‑16: Units Sold by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 | 875 |
Figure 22‑17: Average Selling Price by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (€) | 876 |
Figure 22‑18: Average Selling Price by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (US$) | 877 |
Figure 22‑19: Market Value by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (€M) | 878 |
Figure 22‑20: Market Value by Country, Guiding Introducer Sheath Market, Europe, 2019 – 2029 (US$M) | 879 |
Figure 22‑21: Leading Competitors, Introducer Sheath Market, Europe, 2022 | 883 |
Figure 23‑1: Vascular Closure Device Market by Device Type, Europe, 2019 – 2029 (€M) | 887 |
Figure 23‑2: Vascular Closure Device Market by Device Type, Europe, 2019 – 2029 (US$M) | 888 |
Figure 23‑3: Vascular Closure Device Market by Approach, Europe, 2019 – 2029 (€M) | 889 |
Figure 23‑4: Vascular Closure Device Market by Approach, Europe, 2019 – 2029 (US$M) | 890 |
Figure 23‑5: Total Vascular Closure Device Market, Europe, 2019 – 2029 | 892 |
Figure 23‑6: Units Sold by Country, Vascular Closure Device Market, Europe, 2019 – 2029 | 893 |
Figure 23‑7: Average Selling Price by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 894 |
Figure 23‑8: Average Selling Price by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 895 |
Figure 23‑9: Market Value by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 896 |
Figure 23‑10: Market Value by Country, Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 897 |
Figure 23‑11: Invasive Vascular Closure Device Market by Segment, Europe, 2019 – 2029 (€M) | 898 |
Figure 23‑12: Invasive Vascular Closure Device Market by Segment, Europe, 2019 – 2029 (US$M) | 899 |
Figure 23‑13: Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 | 899 |
Figure 23‑14: Units Sold by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 | 900 |
Figure 23‑15: Average Selling Price by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 901 |
Figure 23‑16: Average Selling Price by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 902 |
Figure 23‑17: Market Value by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 903 |
Figure 23‑18: Market Value by Country, Total Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 904 |
Figure 23‑19: Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 | 905 |
Figure 23‑20: Units Sold by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 | 906 |
Figure 23‑21: Average Selling Price by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 907 |
Figure 23‑22: Average Selling Price by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 908 |
Figure 23‑23: Market Value by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 909 |
Figure 23‑24: Market Value by Country, Small-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 910 |
Figure 23‑25: Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 | 912 |
Figure 23‑26: Units Sold by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 | 913 |
Figure 23‑27: Average Selling Price by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 914 |
Figure 23‑28: Average Selling Price by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 915 |
Figure 23‑29: Market Value by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 916 |
Figure 23‑30: Market Value by Country, Large-Bore Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 917 |
Figure 23‑31: Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 | 918 |
Figure 23‑32: Units Sold by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 | 919 |
Figure 23‑33: Average Selling Price by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 920 |
Figure 23‑34: Average Selling Price by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 921 |
Figure 23‑35: Market Value by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 922 |
Figure 23‑36: Market Value by Country, Non-Invasive Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 923 |
Figure 23‑37: Radial Vascular Closure Device Market, Europe, 2019 – 2029 | 924 |
Figure 23‑38: Units Sold by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 | 925 |
Figure 23‑39: Average Selling Price by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 926 |
Figure 23‑40: Average Selling Price by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 927 |
Figure 23‑41: Market Value by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 928 |
Figure 23‑42: Market Value by Country, Radial Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 929 |
Figure 23‑43: Femoral Vascular Closure Device Market, Europe, 2019 – 2029 | 930 |
Figure 23‑44: Units Sold by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 | 931 |
Figure 23‑45: Average Selling Price by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (€) | 932 |
Figure 23‑46: Average Selling Price by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (US$) | 933 |
Figure 23‑47: Market Value by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (€M) | 934 |
Figure 23‑48: Market Value by Country, Femoral Vascular Closure Device Market, Europe, 2019 – 2029 (US$M) | 935 |
Figure 23‑49: Leading Competitors, Vascular Closure Device Market by Device Type, Europe, 2022 | 941 |
Figure 23‑50: Leading Competitors, Vascular Closure Device Market by Approach, Europe, 2022 | 941 |
Figure 24‑1: Transcatheter Embolization Market by Segment, Europe, 2019 – 2029 (€M) | 946 |
Figure 24‑2: Transcatheter Embolization Market by Segment, Europe, 2019 – 2029 (US$M) | 947 |
Figure 24‑3: Particle Embolization Market by Segment, Europe, 2019 – 2029 (€M) | 951 |
Figure 24‑4: Particle Embolization Market by Segment, Europe, 2019 – 2029 (US$M) | 951 |
Figure 24‑5: Particle Embolization Market, Europe, 2019 – 2029 | 952 |
Figure 24‑6: Units Sold by Country, Particle Embolization Market, Europe, 2019 – 2029 | 953 |
Figure 24‑7: Average Selling Price by Country, Particle Embolization Market, Europe, 2019 – 2029 (€) | 954 |
Figure 24‑8: Average Selling Price by Country, Particle Embolization Market, Europe, 2019 – 2029 (US$) | 955 |
Figure 24‑9: Market Value by Country, Particle Embolization Market, Europe, 2019 – 2029 (€M) | 956 |
Figure 24‑10: Market Value by Country, Particle Embolization Market, Europe, 2019 – 2029 (US$M) | 957 |
Figure 24‑11: PVA Particle Market, Europe, 2019 – 2029 | 958 |
Figure 24‑12: Units Sold by Country, PVA Particle Market, Europe, 2019 – 2029 | 959 |
Figure 24‑13: Average Selling Price by Country, PVA Particle Market, Europe, 2019 – 2029 (€) | 960 |
Figure 24‑14: Average Selling Price by Country, PVA Particle Market, Europe, 2019 – 2029 (US$) | 961 |
Figure 24‑15: Market Value by Country, PVA Particle Market, Europe, 2019 – 2029 (€M) | 962 |
Figure 24‑16: Market Value by Country, PVA Particle Market, Europe, 2019 – 2029 (US$M) | 963 |
Figure 24‑17: Microsphere Market, Europe, 2019 – 2029 | 964 |
Figure 24‑18: Units Sold by Country, Microsphere Market, Europe, 2019 – 2029 | 965 |
Figure 24‑19: Average Selling Price by Country, Microsphere Market, Europe, 2019 – 2029 (€) | 966 |
Figure 24‑20: Average Selling Price by Country, Microsphere Market, Europe, 2019 – 2029 (US$) | 967 |
Figure 24‑21: Market Value by Country, Microsphere Market, Europe, 2019 – 2029 (€M) | 968 |
Figure 24‑22: Market Value by Country, Microsphere Market, Europe, 2019 – 2029 (US$M) | 969 |
Figure 24‑23: Drug-Eluting Particle Market, Europe, 2019 – 2029 | 970 |
Figure 24‑24: Units Sold by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 | 971 |
Figure 24‑25: Average Selling Price by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (€) | 972 |
Figure 24‑26: Average Selling Price by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (US$) | 973 |
Figure 24‑27: Market Value by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (€M) | 974 |
Figure 24‑28: Market Value by Country, Drug-Eluting Particle Market, Europe, 2019 – 2029 (US$M) | 975 |
Figure 24‑29: Radioactive Particle Market, Europe, 2019 – 2029 | 976 |
Figure 24‑30: Units Sold by Country, Radioactive Particle Market, Europe, 2019 – 2029 | 977 |
Figure 24‑31: Average Selling Price by Country, Radioactive Particle Market, Europe, 2019 – 2029 (€) | 978 |
Figure 24‑32: Average Selling Price by Country, Radioactive Particle Market, Europe, 2019 – 2029 (US$) | 979 |
Figure 24‑33: Market Value by Country, Radioactive Particle Market, Europe, 2019 – 2029 (€M) | 980 |
Figure 24‑34: Market Value by Country, Radioactive Particle Market, Europe, 2019 – 2029 (US$M) | 981 |
Figure 24‑35: Coil Embolization Market by Segment, Europe, 2019 – 2029 (€M) | 983 |
Figure 24‑36: Coil Embolization Market by Segment, Europe, 2019 – 2029 (US$M) | 983 |
Figure 24‑37: Total Coil Embolization Market, Europe, 2019 – 2029 | 984 |
Figure 24‑38: Units Sold by Country, Total Coil Embolization Market, Europe, 2019 – 2029 | 985 |
Figure 24‑39: Average Selling Price by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (€) | 986 |
Figure 24‑40: Average Selling Price by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (US$) | 987 |
Figure 24‑41: Market Value by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (€M) | 988 |
Figure 24‑42: Market Value by Country, Total Coil Embolization Market, Europe, 2019 – 2029 (US$M) | 989 |
Figure 24‑43: Pushable Coil Market, Europe, 2019 – 2029 | 990 |
Figure 24‑44: Units Sold by Country, Pushable Coil Market, Europe, 2019 – 2029 | 991 |
Figure 24‑45: Average Selling Price by Country, Pushable Coil Market, Europe, 2019 – 2029 (€) | 992 |
Figure 24‑46: Average Selling Price by Country, Pushable Coil Market, Europe, 2019 – 2029 (US$) | 993 |
Figure 24‑47: Market Value by Country, Pushable Coil Market, Europe, 2019 – 2029 (€M) | 994 |
Figure 24‑48: Market Value by Country, Pushable Coil Market, Europe, 2019 – 2029 (US$M) | 995 |
Figure 24‑49: Detachable Coil Market, Europe, 2019 – 2029 | 996 |
Figure 24‑50: Units Sold by Country, Detachable Coil Market, Europe, 2019 – 2029 | 997 |
Figure 24‑51: Average Selling Price by Country, Detachable Coil Market, Europe, 2019 – 2029 (€) | 998 |
Figure 24‑52: Average Selling Price by Country, Detachable Coil Market, Europe, 2019 – 2029 (US$) | 999 |
Figure 24‑53: Market Value by Country, Detachable Coil Market, Europe, 2019 – 2029 (€M) | 1000 |
Figure 24‑54: Market Value by Country, Detachable Coil Market, Europe, 2019 – 2029 (US$M) | 1001 |
Figure 24‑55: Liquid Embolization Market, Europe, 2019 – 2029 | 1002 |
Figure 24‑56: Units Sold by Country, Liquid Embolization Market, Europe, 2019 – 2029 | 1003 |
Figure 24‑57: Average Selling Price by Country, Liquid Embolization Market, Europe, 2019 – 2029 (€) | 1004 |
Figure 24‑58: Average Selling Price by Country, Liquid Embolization Market, Europe, 2019 – 2029 (US$) | 1005 |
Figure 24‑59: Market Value by Country, Liquid Embolization Market, Europe, 2019 – 2029 (€M) | 1006 |
Figure 24‑60: Market Value by Country, Liquid Embolization Market, Europe, 2019 – 2029 (US$M) | 1007 |
Figure 24‑61: Plug Embolization Market, Europe, 2019 – 2029 | 1009 |
Figure 24‑62: Units Sold by Country, Plug Embolization Market, Europe, 2019 – 2029 | 1010 |
Figure 24‑63: Average Selling Price by Country, Plug Embolization Market, Europe, 2019 – 2029 (€) | 1011 |
Figure 24‑64: Average Selling Price by Country, Plug Embolization Market, Europe, 2019 – 2029 (US$) | 1012 |
Figure 24‑65: Market Value by Country, Plug Embolization Market, Europe, 2019 – 2029 (€M) | 1013 |
Figure 24‑66: Market Value by Country, Plug Embolization Market, Europe, 2019 – 2029 (US$M) | 1014 |
Figure 24‑67: Leading Competitors, Transcatheter Embolization Market, Europe, 2022 | 1021 |
Figure 25‑1: Peripheral IVUS Market, Europe, 2019 – 2029 | 1026 |
Figure 25‑2: Units Sold by Country, Peripheral IVUS Market, Europe, 2019 – 2029 | 1028 |
Figure 25‑3: Average Selling Price by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (€) | 1029 |
Figure 25‑4: Average Selling Price by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (US$) | 1030 |
Figure 25‑5: Market Value by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (€M) | 1031 |
Figure 25‑6: Market Value by Country, Peripheral IVUS Market, Europe, 2019 – 2029 (US$M) | 1032 |
Figure 25‑7: Leading Competitors, Peripheral IVUS Market, Europe, 2022 | 1036 |